$MIST

$0.75▲ +2.7% YTD

5 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History

News

MIST ▲ +2.7% - Milestone Pharmaceuticals Inc.

CP $0.75▲ +2.7%Nov 3, 2026 · ThinkSabio Blog

$MIST - Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026…

News

MIST ▲ +7.0% - Milestone Pharmaceuticals Inc.

CP $0.76▲ +7.0%Oct 9, 2026 · ThinkSabio Blog

$MIST - Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial…

News

MIST ▲ +2.3% - Milestone Pharmaceuticals Inc.

CP $0.88▲ +2.3%Sep 24, 2026 · ThinkSabio Blog

$MIST - Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AF…

News

MIST ▲ +5.9% - Milestone Pharmaceuticals Inc.

CP $1.25▲ +5.9%Sep 3, 2026 · ThinkSabio Blog

$MIST - Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil O…

News

MIST ▼ -0.9% - Milestone Pharmaceuticals Inc.

CP $1.13▲ -0.9%Sep 2, 2026 · ThinkSabio Blog

$MIST - Milestone Pharmaceuticals to Present at Upcoming Investor Conferences…